Group One Trading
HUMA icon

Group One Trading’s Humacyte HUMA Stock Holding History

Group One Trading’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.8K Sell
55,700
-7,300
-12% -$7.59K ﹤0.01% 5557
2025
Q4 		$60.5K Buy
63,000
+15,500
+33% +$21.9K ﹤0.01% 5437
2025
Q3 		$82.7K Sell
47,500
-96,900
-67% -$190K ﹤0.01% 5520
2025
Q2 		$302K Sell
144,400
-68,100
-32% -$131K ﹤0.01% 3929
2025
Q1 		$362K Buy
212,500
+37,300
+21% +$140K ﹤0.01% 3412
2024
Q4 		$885K Buy
175,200
+116,500
+198% +$576K ﹤0.01% 2683
2024
Q3 		$319K Sell
58,700
-173,500
-75% -$1.14M ﹤0.01% 3212
2024
Q2 		$1.11M Buy
232,200
+229,200
+7,640% +$1.19M ﹤0.01% 1901
2024
Q1 		$9.33K Buy
3,000
+2,500
+500% +$8.41K ﹤0.01% 5907
2023
Q4 		$1.42K Sell
500
-10,000
-95% -$25.7K ﹤0.01% 6913
2023
Q3 		$30.8K Buy
10,500
+3,000
+40% +$9.93K ﹤0.01% 5521
2023
Q2 		$21.4K Sell
7,500
-20,500
-73% -$73.9K ﹤0.01% 5951
2023
Q1 		$86.5K Buy
+28,000
New +$79.6K ﹤0.01% 4421
2022
Q4 		– Sell
-6,900
Closed -$22K – 7605
2022
Q3 		$22K Sell
6,900
-1,900
-22% -$7.29K ﹤0.01% 6004
2022
Q2 		$28K Sell
8,800
-42,200
-83% -$235K ﹤0.01% 6034
2022
Q1 		$360K Sell
51,000
-12,200
-19% -$71K ﹤0.01% 4185
2021
Q4 		$458K Buy
63,200
+9,700
+18% +$95.9K ﹤0.01% 4235
2021
Q3 		$621K Buy
+53,500
New +$612K ﹤0.01% 3954

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's HUMA Position: Q1 2026 in Review

Group One Trading reduced its Humacyte (HUMA) stake by 19% in Q1 2026, selling an estimated $51.1K and leaving 215,476 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #4481.

Group One Trading first reported a position in HUMA in Q3 2021 and has held it in 14 quarters since. The position peaked at $301K in Q3 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Group One Trading held 215,476 shares of Humacyte worth $131K as of Q1 2026.
  • Group One Trading sold 49,121 Humacyte shares in Q1 2026, an estimated $51.1K.
  • Humacyte made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4481 holding.
  • Group One Trading first reported a position in Humacyte in Q3 2021 and has held it in 14 quarters since.
  • Group One Trading's Humacyte position peaked at $301K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.